Publication Information

{'id': 'https://openalex.org/W2593296711', 'doi': 'https://doi.org/10.1158/2326-6074.tumimm16-a29', 'title': 'Abstract A29: Anti-CTLA-4 antibody scFv producing recombinant Bifidobacterium secretes CTLA-4 blocker specifically inside hypoxic tumor and suppresses tumor growth in syngeneic mice model', 'display_name': 'Abstract A29: Anti-CTLA-4 antibody scFv producing recombinant Bifidobacterium secretes CTLA-4 blocker specifically inside hypoxic tumor and suppresses tumor growth in syngeneic mice model', 'publication_year': 2017, 'publication_date': '2017-02-28', 'ids': {'openalex': 'https://openalex.org/W2593296711', 'doi': 'https://doi.org/10.1158/2326-6074.tumimm16-a29', 'mag': '2593296711'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/2326-6074.tumimm16-a29', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765010658', 'display_name': 'Cancer Immunology Research', 'issn_l': '2326-6066', 'issn': ['2326-6066', '2326-6074'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5020284001', 'display_name': 'Koichiro Shioya', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Koichiro Shioya', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113801931', 'display_name': 'Shiro Kataoka', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shiro Kataoka', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107889976', 'display_name': 'Li Wang', 'orcid': 'https://orcid.org/0000-0003-3722-5986'}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Li Wang', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113794608', 'display_name': 'Tomio Matsumura', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tomio Matsumura', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078055927', 'display_name': 'Hitomi Shimizu', 'orcid': 'https://orcid.org/0000-0001-5941-859X'}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hitomi Shimizu', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065067772', 'display_name': 'Yasuyoshi Kanari', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yasuyoshi Kanari', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031542930', 'display_name': 'Yuji Seki', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuji Seki', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081873449', 'display_name': 'Yuko Shimatani', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuko Shimatani', 'raw_affiliation_strings': ['1Anaeropharma Science, Inc., Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': '1Anaeropharma Science, Inc., Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003618602', 'display_name': 'Maiko Fujimori', 'orcid': 'https://orcid.org/0000-0003-1639-3390'}, 'institutions': [{'id': 'https://openalex.org/I4210135408', 'display_name': 'Tokyo Medical University Ibaraki Medical Center', 'ror': 'https://ror.org/031hmx230', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210135408']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Minoru Fujimori', 'raw_affiliation_strings': ['2Department of Breast Surgery, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan,'], 'affiliations': [{'raw_affiliation_string': '2Department of Breast Surgery, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan,', 'institution_ids': ['https://openalex.org/I4210135408']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5045278129', 'display_name': 'Shun’ichiro Taniguchi', 'orcid': 'https://orcid.org/0000-0003-3245-6670'}, 'institutions': [{'id': 'https://openalex.org/I137975476', 'display_name': 'Shinshu University', 'ror': 'https://ror.org/0244rem06', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I137975476']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': "Shun'ichiro Taniguchi", 'raw_affiliation_strings': ['3Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Nagano, Japan.'], 'affiliations': [{'raw_affiliation_string': '3Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Nagano, Japan.', 'institution_ids': ['https://openalex.org/I137975476']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.530539, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 71, 'max': 75}, 'biblio': {'volume': '5', 'issue': '3_Supplement', 'first_page': 'A29', 'last_page': 'A29'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10602', 'display_name': 'Glycosylation and Glycoproteins Research', 'score': 0.9936, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cancer-immunotherapy', 'display_name': 'Cancer Immunotherapy', 'score': 0.6201336}, {'id': 'https://openalex.org/keywords/blocking-antibody', 'display_name': 'Blocking antibody', 'score': 0.42371535}], 'concepts': [{'id': 'https://openalex.org/C2780674031', 'wikidata': 'https://www.wikidata.org/wiki/Q2012719', 'display_name': 'Cancer immunotherapy', 'level': 4, 'score': 0.6201336}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.6196021}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.61785924}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.5755209}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5664573}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5089216}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.49960732}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.47403243}, {'id': 'https://openalex.org/C45121317', 'wikidata': 'https://www.wikidata.org/wiki/Q4927287', 'display_name': 'Blocking antibody', 'level': 3, 'score': 0.42371535}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.36022198}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.13378412}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/2326-6074.tumimm16-a29', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765010658', 'display_name': 'Cancer Immunology Research', 'issn_l': '2326-6066', 'issn': ['2326-6066', '2326-6074'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4313343001', 'https://openalex.org/W4223914026', 'https://openalex.org/W3185708072', 'https://openalex.org/W3111580887', 'https://openalex.org/W3049036915', 'https://openalex.org/W2999675030', 'https://openalex.org/W2893846263', 'https://openalex.org/W2806333505', 'https://openalex.org/W2761992239', 'https://openalex.org/W2400599632'], 'abstract_inverted_index': {'Abstract': [0], 'Success': [1], 'of': [2, 46, 53, 66, 75, 89, 192, 197, 211, 220, 258, 272, 368], 'immune': [3, 68], 'checkpoint': [4], 'antibody': [5, 15, 18, 60, 172, 266, 297, 316, 345], 'drugs': [6], 'has': [7, 201], 'provided': [8], 'broad': [9], 'perspective': [10], 'in': [11, 100, 109, 124, 143, 176, 198, 282, 287, 319, 361], 'cancer': [12, 54, 177, 320], 'immunotherapy.': [13, 61, 321], 'Anti-PD-1': [14], 'and': [16, 22, 104, 127, 140, 185, 209, 224, 263, 309, 357, 376], 'anti-CTLA-4': [17, 296], 'showed': [19], 'notable': [20], 'efficacy': [21], 'the': [23, 59, 71, 80, 86, 94, 102, 106, 144, 164, 189, 206, 217, 225, 245, 255, 369], 'combination': [24, 34, 256], 'complimentarily': [25], 'enhanced': [26], 'antitumor': [27], 'benefit.': [28], 'Nevertheless,': [29], 'either': [30], 'single-agent': [31], 'therapy': [32, 35, 72, 257], 'or': [33, 157, 230], 'is': [36, 43, 73, 275], 'facing': [37], 'immune-related': [38], 'adverse': [39], 'events': [40], '(irAEs),': [41], 'which': [42, 98, 138, 179], 'major': [44, 76], 'cause': [45, 79], 'treatment': [47], 'discontinuation.': [48], 'Also,': [49], 'still': [50], 'large': [51], 'fraction': [52], 'patients': [55], "doesn't": [56], 'respond': [57], 'to': [58, 78, 84, 114, 184, 204, 244, 304], 'Since': [62], 'non-specific': [63], 'systemic': [64], 'activation': [65], 'normal': [67], 'system': [69], 'by': [70, 131, 214, 290], 'one': [74], 'reasons': [77], 'above': [81], 'problems,': [82], 'approaches': [83], 'target': [85, 305], 'hypoxic': [87, 145, 190, 306, 355], 'condition': [88], 'tumors': [90, 149, 308], 'may': [91], 'help': [92], 'increasing': [93], "drug's": [95], 'tumor-targeting': [96], 'specificity,': [97], 'results': [99], 'minimizing': [101], 'irAEs': [103], 'improving': [105], 'response': [107], 'rate': [108], 'patients.': [110], 'In': [111], 'an': [112], 'aim': [113], 'improve': [115], 'anti-cancer': [116], 'drug': [117, 317], 'delivery': [118, 318], 'efficacy,': [119], 'we': [120, 168], 'have': [121], 'been': [122, 202], 'developing': [123], 'situ': [125], 'Delivery': [126], 'Production': [128], 'System': [129], '(i-DPS)': [130], 'modifying': [132], 'a': [133, 299, 312], 'non-pathogenic': [134], 'anaerobic': [135], 'bacterium,': [136], 'Bifidobacterium,': [137, 216], 'localizes': [139], 'proliferates': [141], 'only': [142, 187, 280], 'environment': [146], 'like': [147], 'solid': [148, 193, 307], 'after': [150], 'intravenous': [151], 'administration,': [152], 'produces': [153], 'anticancer': [154], 'proteins,': [155], 'enzymes': [156], 'other': [158], 'pharmacologically': [159], 'active': [160], 'molecules': [161], 'selectively': [162], 'at': [163, 188], 'tumor': [165, 251, 283, 356, 359], 'site.': [166], 'Here': [167], 'present': [169], 'anti-human': [170], 'CTLA-4': [171, 236, 351], 'scFv': [173, 213, 223, 237, 260, 278, 346], 'producing': [174, 238, 261, 347], 'i-DPS': [175, 294], 'immunotherapy,': [178], 'could': [180], 'be': [181], 'specifically': [182, 353], 'delivered': [183], 'amplified': [186], 'sites': [191], 'tumors.': [194], 'A': [195], 'series': [196], 'vitro': [199], 'assays': [200], 'performed': [203], 'confirm': [205], 'stable': [207], 'expression': [208], 'secretion': [210], 'anti-hCTLA-4': [212, 222], 'recombinant': [215, 348], 'binding': [218], 'affinity': [219], 'purified': [221], 'IC50': [226], 'competing': [227], 'with': [228], 'hCTLA-4/hCD80': [229], 'hCD86': [231], 'interaction': [232], 'as': [233, 240], 'well.': [234], 'Anti-murine': [235], 'Bifidobacterium': [239, 262, 349], 'surrogate': [241], 'systemically': [242], 'administered': [243], 'syngeneic': [246, 362], 'mice': [247, 363], 'model': [248], 'demonstrated': [249], 'significant': [250], 'growth': [252, 360], 'inhibition.': [253], 'Moreover,': [254], 'anti-mCTLA-4': [259], 'anti-murine': [264], 'PD-1': [265], 'was': [267, 279], 'more': [268], 'effective': [269], 'than': [270], 'each': [271], 'monotherapy.': [273], 'It': [274], 'noteworthy': [276], 'that': [277], 'detected': [281], 'tissue': [284], 'but': [285], 'not': [286], 'blood': [288], 'proved': [289], 'immunoprecipitation': [291], 'assay.': [292], 'Altogether,': [293], 'for': [295, 315], 'provide': [298, 311], 'new': [300], 'promising': [301], 'immune-therapeutic': [302], 'modality': [303], 'also': [310], 'unique': [313], 'insight': [314], 'Citation': [322], 'Format:': [323], 'Koichiro': [324], 'Shioya,': [325], 'Shiro': [326], 'Kataoka,': [327], 'Li': [328], 'Wang,': [329], 'Tomio': [330], 'Matsumura,': [331], 'Hitomi': [332], 'Shimizu,': [333], 'Yasuyoshi': [334], 'Kanari,': [335], 'Yuji': [336], 'Seki,': [337], 'Yuko': [338], 'Shimatani,': [339], 'Minoru': [340], 'Fujimori,': [341], "Shun'ichiro": [342], 'Taniguchi.': [343], 'Anti-CTLA-4': [344], 'secretes': [350], 'blocker': [352], 'inside': [354], 'suppresses': [358], 'model.': [364], '[abstract].': [365], 'In:': [366], 'Proceedings': [367], 'AACR': [370], 'Special': [371], 'Conference': [372], 'on': [373], 'Tumor': [374], 'Immunology': [375], 'Immunotherapy;': [377], '2016': [378], 'Oct': [379], '20-23;': [380], 'Boston,': [381], 'MA.': [382], 'Philadelphia': [383], '(PA):': [384], 'AACR;': [385], 'Cancer': [386], 'Immunol': [387], 'Res': [388], '2017;5(3': [389], 'Suppl):Abstract': [390], 'nr': [391], 'A29.': [392]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2593296711', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-19T12:34:54.135657', 'created_date': '2017-03-16'}